Law360, New York (September 28, 2011, 4:07 PM ET) -- The Federal Circuit on Wednesday upheld a Delaware federal court ruling in a long-running dispute over heart stent technology, finding that Boston Scientific Corp. did not infringe a patent held by Johnson & Johnson subsidiary Cordis Corp. covering stents.
The appeals court upheld the decision by U.S. District Judge Sue L. Robinson, which granted of judgment as a matter of law that one of Cordis’ patents was not infringed by a Boston Scientific heart stent. However, the Federal Circuit also upheld the decision that the court...
Boston Sci Didn't Infringe Cordis Stent IP: Fed. Circ.
To view the full article, take a free trial now.
